Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.

Journal Article (Journal Article;Review)

PURPOSE OF REVIEW: The prevalence of Hepatitis C virus (HCV) in the US incarcerated population is disproportionately high, and when inmates with infection are released back into the general population, they play a substantial role in the spread of disease. This review provides support for targeting the jail/prison population to eliminate HCV in the general population. It will also summarize various screening/treatment models to curtail the burden of disease behind and beyond bars. RECENT FINDINGS: Transitioning from risk-based testing to opt-out testing in prisons/jails would be cost-effective through greater identification of cases and treatment to prevent complications from cirrhosis. Other innovative strategies, such as the nominal pricing mechanism or the "Netflix" DAA subscription model, have the potential to be cost-effective and to increase access to treatment. Addressing HCV in the incarcerated population is a strategy to bring the US closer to successfully eradicating the epidemic. Such findings should incentivize policymakers to implement care models that target this population.

Full Text

Duke Authors

Cited Authors

  • Ocal, S; Muir, AJ

Published Date

  • February 2020

Published In

Volume / Issue

  • 17 / 1

Start / End Page

  • 18 - 25

PubMed ID

  • 31933274

Pubmed Central ID

  • 31933274

Electronic International Standard Serial Number (EISSN)

  • 1548-3576

Digital Object Identifier (DOI)

  • 10.1007/s11904-019-00476-z

Language

  • eng

Conference Location

  • United States